FDA Adverse Event Malfunction Summary report: N

APEX¿

MDR report key: 2901557 · Received January 8, 2013

Report

Report Number
2134265-2012-08263
Event Type
Malfunction
Date Received
January 8, 2013
Date of Event
December 12, 2012
Report Date
December 12, 2012
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
LOX
PMA / PMN Number
P860019
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

AGE AT TIME OF EVENT: (B)(6). DEVICE EVALUATED BY MANUFACTURER: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE, A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED. (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A STENTING TREATMENT PROCEDURE, A BALLOON RUPTURE OCCURRED THE PROCEDURE TREATED THE 90% STENOSED TARGET LESION LOCATED IN THE SEVERELY CALCIFIED AND SEVERELY TORTUOUS PROXIMAL LEFT CIRCUMFLEX ARTERY. A 2.0X20MM NON-BSC BALLOON CATHETER WAS ADVANCED AND INFLATED. NEXT A 2.5X24MM TAXUS ELEMENT STENT WAS ADVANCED FOR TREATMENT, BUT WAS NOT ABLE TO CROSS THE LESION. THEN A 2.5X20MM QUANTUM MAVERICK BALLOON WAS ADVANCED, BUT IT WAS NOT ABLE TO CROSS THE LESION. A 2.5X15MM APEX BALLOON WAS THEN ADVANCED AND INFLATED, HOWEVER THE BALLOON RUPTURED AT 5 ATMS. THEN A 2.5MM NON-BSC BALLOON CATHETER WAS ADVANCED BUT WAS NOT ABLE TO CROSS THE LESION. FINALLY A 2.5MM NON-BSC BALLOON CATHETER WAS ADVANCED AND INFLATED BUT IT ALSO RUPTURED. THE PROCEDURE WAS COMPLETED WITHOUT STENTING. NO PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT STATUS IS STABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
8823 APEX¿ CATHETERS, TRANSLUMINAL CORONARY ANGIOPLASTY, PERCUTANEOUS LOX BOSTON SCIENTIFIC - GALWAY H7493895915250 15354669

Patients

Seq Age Sex Outcome Treatment
1